-
1
Study investigates reuse of COVID-19 blood samples for leprosy detection.
-
2
Identified 12 undiagnosed leprosy cases in Brazil.
-
3
New antibody markers against Mycobacterium leprae performed better than PGL-I.
-
4
Integrating symptom questionnaires with serology improves sensitivity.
-
5
Widespread leprosy transmission indicated, requiring broader screening.
-
6
Highlights importance of existing sample collections for disease surveillance.
Original Source(s)
Related Content
Jonathan Van-Tam on COVID’s Next Phase
Former UK Deputy Chief Medical Officer discusses new protein-based vaccines, declining uptake, and the ongoing risks of COVID-19
April 14, 2026
-
7 min
Expanding Access to TB Testing
WHO recommends near point-of-care tests, tongue swabs, and pooling strategies
April 14, 2026
-
2 min
Antivirals Linked to Lower Hospitalization in Influenza
Matched cohort study in nonhospitalized patients
April 13, 2026
-
3 min
